Pharmacokinetic‐Pharmacodynamic (Dipeptidyl Peptidase‐4...

  • Main
  • 2019 / 08
  • Pharmacokinetic‐Pharmacodynamic (Dipeptidyl Peptidase‐4...

Pharmacokinetic‐Pharmacodynamic (Dipeptidyl Peptidase‐4 Inhibition) Model to Support Dose Rationale in Diabetes Patients, Including Those with Renal Impairment, for the Once‐Weekly Administered Omarigliptin

Jain, Lokesh, Chain, Anne S.Y., Tatosian, Daniel A., Hing, Jeremy, Passarell, Julie A., Kauh, Eunkyung A., Lai, Eseng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.14103
Date:
August, 2019
File:
PDF, 433 KB
2019
Conversion to is in progress
Conversion to is failed